2018
Rationale, development, and design of the Altering Intake, Managing Symptoms (AIMS) dietary intervention for bowel dysfunction in rectal cancer survivors.
Sun V, Crane TE, Slack SD, Yung A, Wright S, Sentovich S, Melstrom K, Fakih M, Krouse RS, Thomson CA. 2018. Rationale, development, and design of the Altering Intake, Managing Symptoms (AIMS) dietary intervention for bowel dysfunction in rectal cancer survivors. Contemp Clin Trials. 68:61–66. doi:10.1016/j.cct.2018.03.010.
Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH, leads to hMC1R selectivity and pigmentation.
Mowlazadeh Haghighi S, Zhou Y, Dai J, Sawyer JR, Hruby VJ, Cai M. 2018. Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH, leads to hMC1R selectivity and pigmentation. Eur J Med Chem. 151:815–823. doi:10.1016/j.ejmech.2018.04.021.
Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification.
Mesko S, Marks L, Ragab O, Patel S, Margolis DA, Demanes DJ, Kamrava M. 2018. Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification. Am J Clin Oncol. 41:497–501. doi:10.1097/COC.0000000000000308.
An ordered pattern of Ana2 phosphorylation by Plk4 is required for centriole assembly.
McLamarrah TA, Buster DW, Galletta BJ, Boese CJ, Ryniawec JM, Hollingsworth NA, Byrnes AE, Brownlee CW, Slep KC, Rusan NM, et al. 2018. An ordered pattern of Ana2 phosphorylation by Plk4 is required for centriole assembly. J Cell Biol. 217:1217–1231. doi:10.1083/jcb.201605106.
Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women’s Health Initiative.
Thomson CA, Crane TE, Garcia DO, Wertheim BC, Hingle M, Snetselaar L, Datta M, Rohan T, LeBlanc E, Chlebowski RT, et al. 2018. Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women’s Health Initiative. J Acad Nutr Diet. 118:617–626. doi:10.1016/j.jand.2017.06.010.
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.
Barney CL, Walston S, Zamora P, Healy EH, Nolan N, Diavolitsis VM, Neki A, Rupert R, Savvides P, Agrawal A, et al. 2018. Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma. Oral Oncol. 79:9–14. doi:10.1016/j.oraloncology.2018.02.001.
Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors.
Fang K, Dong G, Li Y, He S, Wu Y, Wu S, Wang W, Sheng C. 2018. Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors. ACS Med Chem Lett. 9:312–317. doi:10.1021/acsmedchemlett.7b00487.
Mentorship in Medicine and Other Health Professions.
Henry-Noel N, Bishop M, Gwede CK, Petkova E, Szumacher E. 2018 Apr. Mentorship in Medicine and Other Health Professions. J Cancer Educ. doi:10.1007/s13187-018-1360-6.
Pancreatic cancer cell detection by targeted lipid microbubbles and multiphoton imaging.
Cromey B, McDaniel A, Matsunaga T, Vagner J, Kieu KQ, Banerjee B. 2018. Pancreatic cancer cell detection by targeted lipid microbubbles and multiphoton imaging. J Biomed Opt. 23:1–8. doi:10.1117/1.JBO.23.4.046501.
A gender- and culturally-sensitive weight loss intervention for Hispanic males: The ANIMO randomized controlled trial pilot study protocol and recruitment methods.
Garcia DO, Valdez LA, Bell ML, Humphrey K, Hingle M, McEwen M, Hooker SP. 2018. A gender- and culturally-sensitive weight loss intervention for Hispanic males: The ANIMO randomized controlled trial pilot study protocol and recruitment methods. Contemp Clin Trials Commun. 9:151–163. doi:10.1016/j.conctc.2018.01.010.
In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library.
Wang H, Zhang Y, Yang H, Qin M, Ding X, Liu R, Jiang Y. 2018. In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library. Mol Ther Nucleic Acids. 10:187–198. doi:10.1016/j.omtn.2017.12.003.
Increased O-GlcNAcylation of SNAP29 drives arsenic-induced autophagic dysfunction.
Dodson M, Liu P, Jiang T, Ambrose AJ, Luo G, de la Vega MR, Cholanians AB, Wong PK, Chapman E, Zhang DD. 2018 Mar. Increased O-GlcNAcylation of SNAP29 drives arsenic-induced autophagic dysfunction. Mol Cell Biol. doi:10.1128/MCB.00595-17.
Pneumatosis intestinalis in solid organ transplant recipients.
Gemma V, Mistrot D, Row D, Gagliano RA, Bremner RM, Walia R, Mehta AC, Panchabhai TS. 2018. Pneumatosis intestinalis in solid organ transplant recipients. J Thorac Dis. 10:1984–1997. doi:10.21037/jtd.2018.02.52.
Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo.
Tavares ALP, Brown JA, Ulrich EC, Dvorak K, Runyan RB. 2018. Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo. Dev Dyn. 247:542–554. doi:10.1002/dvdy.24539.
Training Community Health Workers in Motivational Interviewing to Promote Cancer Screening.
Brandford A, Adegboyega A, Combs B, Hatcher J. 2018 Mar. Training Community Health Workers in Motivational Interviewing to Promote Cancer Screening. Health Promot Pract.:1524839918761384. doi:10.1177/1524839918761384.
Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapy.
Ragab O, Banerjee R, Park S-J, Patel S, Zhang M, Wang J, Velez M, Demanes DJ, Kamrava M. 2018. Comparison of patient-reported acute urinary and sexual toxicity scores in a 6- versus 2-fraction course of high-dose-rate prostate brachytherapy monotherapy. J Med Imaging Radiat Oncol. 62:109–115. doi:10.1111/1754-9485.12648.
Polystyrene-Core, Silica-Shell Scintillant Nanoparticles for Low-Energy Radionuclide Quantification in Aqueous Media.
Janczak CM, Calderon IAC, Mokhtari Z, Aspinwall CA. 2018. Polystyrene-Core, Silica-Shell Scintillant Nanoparticles for Low-Energy Radionuclide Quantification in Aqueous Media. ACS Appl Mater Interfaces. 10:4953–4960. doi:10.1021/acsami.7b15943.
A "Pathology Explanation Clinic (PEC)" for Patient-Centered Laboratory Medicine Test Results.
Gibson B, Bracamonte E, Krupinski EA, Briehl MM, Barker GP, Weinstein JB, Weinstein RS. 2018. A "Pathology Explanation Clinic (PEC)" for Patient-Centered Laboratory Medicine Test Results. Acad Pathol. 5:2374289518756306. doi:10.1177/2374289518756306.
A case report of clonidine induced syncope: a review of central actions of an old cardiovascular drug.
Sandweiss AJ, Morrison CM, Spichler A, Rozich J. 2018. A case report of clonidine induced syncope: a review of central actions of an old cardiovascular drug. BMC Pharmacol Toxicol. 19:6. doi:10.1186/s40360-018-0198-1.
A disconnect between precursor frequency, expansion potential, and site-specific CD4+ T cell responses in aged mice.
Deshpande NR, Uhrlaub JL, Way SS, Nikolich-Žugich J, Kuhns MS. 2018. A disconnect between precursor frequency, expansion potential, and site-specific CD4+ T cell responses in aged mice. PLoS One. 13:e0198354. doi:10.1371/journal.pone.0198354.
A dyadic analysis of stress processes in Latinas with breast cancer and their family caregivers.
Segrin C, Badger TA, Sikorskii A, Crane TE, Pace TWW. 2018. A dyadic analysis of stress processes in Latinas with breast cancer and their family caregivers. Psychooncology. 27:838–846. doi:10.1002/pon.4580.
A Novel, Multidisciplinary Approach in the Treatment of Perianal Paget Disease.
Singh J, Row D, Schaub T, Zeitouni NC. 2018. A Novel, Multidisciplinary Approach in the Treatment of Perianal Paget Disease. Dermatol Surg. 44:1653–1655. doi:10.1097/DSS.0000000000001500.
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.
Carducci M, Shaheen M, Markman B, Hurvitz S, Mahadevan D, Kotasek D, Goodman OB, Rasmussen E, Chow V, Juan G, et al. 2018. A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors. Invest New Drugs. 36:1060–1071. doi:10.1007/s10637-018-0625-6.
A randomised controlled trial of an advance care planning intervention for patients with incurable cancer.
Johnson SB, Butow PN, Bell ML, Detering K, Clayton JM, Silvester W, Kiely BE, Clarke S, Vaccaro L, Stockler MR, et al. 2018. A randomised controlled trial of an advance care planning intervention for patients with incurable cancer. Br J Cancer. 119:1182–1190. doi:10.1038/s41416-018-0303-7.
A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility.
Cusanovich DA, Hill AJ, Aghamirzaie D, Daza RM, Pliner HA, Berletch JB, Filippova GN, Huang X, Christiansen L, DeWitt WS, et al. 2018. A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility. Cell. 174:1309–1324.e18. doi:10.1016/j.cell.2018.06.052.